Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients

NCT03197805 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Take care recommendations for Her2 equivok patients has changed.

Conditions

Breast Cancer

Interventions

DIAGNOSTIC_TEST: PAM 50 test

Sponsor

Centre Jean Perrin

Collaborators

[object Object]
[object Object]